Direct determination of protein binding of phenytoin in serum by high-performance liquid chromatography.

A reliable, routine method has been developed which speeds and simplifies the determination of free phenytoin levels in serum. The free fraction of the drug was determined by a single direct injection of serum (350 microL) into a high-performance liquid chromatography (HPLC) system. The mobile phase was a mixture of isopropanol (0.5%) and pH 7.4 phosphate buffer. An internal surface reversed-phase silica column, the Pinkerton column, was used with a flow rate of 1.0 mL/min at ambient temperature, and the wavelength was set at 254 nm. The resolution of free and bound phenytoin peaks was affected by the percentage of isopropanol, the serum volume injected, and the protein concentration in the sample. The concentrations of free and bound drug agreed well with those determined by the conventional ultrafiltration method (MPS-1). The determination of protein binding by HPLC appears to be a satisfactory method for routine therapeutic drug monitoring. The factors affecting the binding and chromatographic separation and the application of this method for clinical use are discussed.

[1]  T. Ohshima,et al.  Comparative Evaluation of Microultrafiltration Devices for Determination of Protein Binding , 1988, Therapeutic drug monitoring.

[2]  T. Nakagawa,et al.  Analysis of warfarin-albumin binding by HPLC with internal-surface reversed-phase silica column. , 1988, Chemical & pharmaceutical bulletin.

[3]  D. Cocchetto,et al.  Protein Binding as a Primary Determinant of the Clinical Pharmacokinetic Properties of Non-Steroidal Anti-Inflammatory Drugs , 1987, Clinical pharmacokinetics.

[4]  B. Chen,et al.  Total and free disopyramide by fluorescence polarization immunoassay and relationship between free fraction and alpha-1 acid glycoprotein. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[5]  B. Ackerman,et al.  Free Drug Monitoring by Liquid Chromatography and Implications for Therapeutic Drug Monitoring , 1987 .

[6]  J. Haginaka,et al.  Retention properties of internal-surface reversed-phase silica packing and recovery of drugs from human plasma. , 1987, Journal of chromatography.

[7]  T. Pinkerton,et al.  Characterization of internal surface reversed-phase silica supports for liquid chromatography. , 1985, Journal of chromatography.

[8]  H. Engelhardt.  Practice of High Performance Liquid Chromatography , 1986 .

[9]  T. Pinkerton,et al.  Characterization of internal surface reversed-phase silica supports for liquid chromatography , 1986 .

[10]  T. Pinkerton,et al.  Production of "internal surface reversed-phase" supports: the hydrolysis of selected substrates from silica using chymotrypsin. , 1986, Journal of chromatography.

[11]  C. March,et al.  Determination of Free Valproic Acid Concentrations Using the Amicon Micropartition MPS‐1 Ultrafiltration System , 1985, Therapeutic drug monitoring.

[12]  L. Love,et al.  Direct injection of untreated serum using nonionic and ionic micellar liquid chromatography for determination of drugs. , 1985, Journal of pharmaceutical and biomedical analysis.

[13]  S. Pond,et al.  First-Pass Elimination Basic Concepts and Clinical Consequences , 1984, Clinical pharmacokinetics.

[14]  B. Sébille,et al.  Study of binding of low-molecular-weight ligand to biological macromolecules by high-performance liquid chromatography. Evaluation of binding parameters for two drugs bound to human serum albumin. , 1978, Journal of chromatography.

[15]  M. Gibaldi.  Biopharmaceutics and clinical pharmacokinetics , 1977 .